معرفی
Julio Silva is a researcher in the Department of Immunobiology at Yale School of Medicine, Yale University. He holds a BS in Molecular, Cell, and Developmental Biology from the University of California, Los Angeles (2015). His work focuses on human immunology, particularly in the context of post-acute infection syndromes such as Long COVID, and immune responses to SARS-CoV-2 infection and vaccination.
- Education: BS, Molecular, Cell, and Developmental Biology, University of California, Los Angeles (2015)
His research interests span immunology, neuroimmunology, sex differences in immunity, vaccine responses, and the pathophysiology of post-viral syndromes. He employs immune profiling, longitudinal cohort studies, and systems biology approaches to understand immune dysregulation in severe and long-term outcomes of viral infections.
Julio Silva's recent publications reveal a strong focus on Long COVID, including immune phenotyping, neurological consequences, and the impact of vaccination. His work also examines sex-based differences in post-infectious syndromes, vaccine effectiveness against Omicron, and the mechanisms of immune failure in fatal cases. These studies are published in top-tier journals such as Nature, Cell, and Science Translational Medicine, indicating high-impact, translational research.
He has no listed scientific awards in the provided text.
Julio Silva collaborates extensively with leading immunologists, including Dr. Akiko Iwasaki, and contributes to research on grants related to infectious diseases and immunology. While no direct mention of grants or advising roles is made, his co-authorship on multiple major studies suggests active participation in funded research programs. He does not appear to supervise students directly based on available data.
His work is conducted within the Immunobiology department at Yale, which supports interdisciplinary research on fundamental and translational immunology, including host-microbe interactions, inflammation, and computational immunology.